Selected article for: "drug pair outcome and pair outcome"

Author: Jennifer C.E Lane; James Weaver; Kristin Kostka; Talita Duarte-Salles; Maria Tereza F. Abrahao; Heba Alghoul; Osaid Alser; Thamir M Alshammari; Patricia Biedermann; Edward Burn; Paula Casajust; Mitch Conover; Aedin C. Culhane; Alexander Davydov; Scott L. DuVall; Dmitry Dymshyts; Sergio Fernández Bertolín; Kristina Fišter; Jill Hardin; Laura Hester; George Hripcsak; Seamus Kent; Sajan Khosla; Spyros Kolovos; Christophe G. Lambert; Johan ver der Lei; Ajit A. Londhe; Kristine E. Lynch; Rupa Makadia; Andrea V. Margulis; Michael E. Matheny; Paras Mehta; Daniel R. Morales; Henry Morgan-Stewart; Mees Mosseveld; Danielle Newby; Fredrik Nyberg; Anna Ostropolets; Rae Woong Park; Albert Prats-Uribe; Gowtham A. Rao; Christian Reich; Jenna Reps; Peter Rijnbeek; Selva Muthu Kumaran Sathappan; Martijn Schuemie; Sarah Seager; Anthony Sena; Azza Shoaibi; Matthew Spotnitz; Marc A. Suchard; Joel Swerdel; Carmen Olga Torre; David Vizcaya; Haini Wen; Marcel de Wilde; Seng Chan You; Lin Zhang; Oleg Zhuk; Patrick Ryan; Daniel Prieto-Alhambra
Title: Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
  • Document date: 2020_4_10
  • ID: 2hbcbvt6_35
    Snippet: This study was undertaken using routinely collected data and all patients meeting the eligibility criteria above during the study observation period were included. No a priori sample calculation was performed; instead, a minimum detectable rate ratio (MDRR) was estimated for each drug-outcome pair . CC-BY-NC 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuit.....
    Document: This study was undertaken using routinely collected data and all patients meeting the eligibility criteria above during the study observation period were included. No a priori sample calculation was performed; instead, a minimum detectable rate ratio (MDRR) was estimated for each drug-outcome pair . CC-BY-NC 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • cc NC International license and rate ratio: 1, 2, 3, 4, 5, 6, 7, 8
    • International license and rate ratio: 1, 2, 3, 4, 5, 6, 7, 8
    • observation period and rate ratio: 1, 2, 3, 4, 5, 6, 7
    • observation period and study observation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • priori sample calculation and sample calculation: 1, 2, 3
    • rate ratio and sample calculation: 1